Background
Fourteen-year-old Taylor Rose Sookra died in December 2021, four months after receiving Pfizer’s COVID-19 vaccine. The medical examiner identified acute cardiac failure due to myocarditis as the cause of death and COVID-19 infection with pneumonitis as a significant condition. Her parents sued Pfizer and federal officials, asserting willful misconduct under the Public Readiness and Emergency Preparedness Act, and brought state-law tort claims against those defendants, Taylor’s physician, and his pediatric practice.
The district court dismissed the federal claims against the government on sovereign-immunity grounds and those against Pfizer for failure to exhaust the PREP Act’s administrative compensation process. It dismissed state-law claims against Pfizer based on PREP Act immunity and declined supplemental jurisdiction over the remaining state-law claims. Although the parents sought a three-judge court after a magistrate judge issued a recommendation, the district court dismissed that request as moot.
The Court’s Holding
The D.C. Circuit held that a single district judge lacked authority to decide the motions to dismiss. The PREP Act states that any willful-misconduct action must initially be assigned to a three-judge panel and gives that panel jurisdiction to consider motions to dismiss, motions for summary judgment, and related matters. That mandatory language covers jurisdictional dismissals as well as dismissals for failure to state a claim.
A single judge may at most dismiss a claim that is so wholly insubstantial and frivolous that it does not colorably arise under the PREP Act. The Sookras’ claims cleared that low threshold: the parties agreed that Pfizer’s vaccine was a covered countermeasure and that the defendants were covered persons. The court therefore vacated the dismissal, reversed the denial of a three-judge court, and remanded with instructions to initiate procedures for convening one.
The court assumed without deciding that the Sookras timely requested a three-judge court because the defendants had not preserved a timeliness objection. It did not decide whether sovereign immunity, failure to exhaust administrative remedies, insufficient supporting medical materials, PREP Act immunity, or any other asserted ground ultimately requires dismissal.
Key Takeaways
- PREP Act willful-misconduct claims must be assigned to a three-judge district court for motions to dismiss, motions for summary judgment, and related matters.
- A single judge may bypass that requirement only for a claim that is wholly insubstantial, obviously frivolous, and insufficient even to present a substantial federal question.
- The decision addresses who must rule on dismissal, not whether the Sookras’ claims survive sovereign-immunity, exhaustion, pleading, or other defenses.
Why It Matters
The ruling gives independent force to the PREP Act’s unusual three-judge procedure. Unlike the generally applicable three-judge-court statute, the PREP Act places key pretrial dispositive motions before the panel rather than a single judge.
Parties litigating PREP Act willful-misconduct claims in the District of Columbia must account for that procedure from the outset. At the same time, the decision provides no ruling on Pfizer’s or the federal defendants’ potential liability and leaves all substantive dismissal questions for the three-judge court.